Compare HIVE & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HIVE | LXRX |
|---|---|---|
| Founded | 1987 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 714.2M | 703.3M |
| IPO Year | 2017 | 2000 |
| Metric | HIVE | LXRX |
|---|---|---|
| Price | $3.95 | $1.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 2 |
| Target Price | ★ $6.44 | $4.15 |
| AVG Volume (30 Days) | ★ 36.1M | 1.9M |
| Earning Date | 02-17-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.78 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $297,791,000.00 | $49,803,000.00 |
| Revenue This Year | $169.51 | N/A |
| Revenue Next Year | $39.45 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 158.32 | 60.24 |
| 52 Week Low | $1.60 | $0.66 |
| 52 Week High | $7.84 | $2.53 |
| Indicator | HIVE | LXRX |
|---|---|---|
| Relative Strength Index (RSI) | 55.58 | 47.47 |
| Support Level | $2.64 | $1.50 |
| Resistance Level | $4.33 | $1.95 |
| Average True Range (ATR) | 0.44 | 0.12 |
| MACD | -0.11 | -0.03 |
| Stochastic Oscillator | 34.69 | 25.81 |
HIVE Digital Technologies Ltd is in the business of providing infrastructure solutions in the blockchain industry. It focuses on the mining and sale of digital currencies. Its geographical segments include Canada, Sweden, Iceland, Switzerland, and Bermuda, out of which the majority of the revenue comes from Bermuda.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.